PTHS
Pelthos Therapeutics Inc.

869
Loading...
Loading...
News
all
press releases
News Placeholder
Pelthos, Ligand Gain After Launch Of First Prescription-At-Home Treatment For Water Warts
The launch triggered a $5 million milestone payment to Ligand, which also holds a 56% stake in Pelthos and is eligible for royalties and additional commercial milestones.
Stocktwits·3mo ago

Latest PTHS News

View

Advertisement. Remove ads.

Advertisement. Remove ads.